Study confirms long-term effects of ‘chemobrain’ in mice

Women undergoing chemotherapy for breast cancer have long complained of lingering cognitive impairments after treatment. These effects are referred to as ‘chemobrain,’ a feeling of mental fogginess. A new study reports long-lasting cognitive impairments in mice when they are administered a chemotherapy regimen used to treat breast cancer in humans.